| pubmed-article:17705579 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17705579 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:17705579 | lifeskim:mentions | umls-concept:C0150369 | lld:lifeskim |
| pubmed-article:17705579 | lifeskim:mentions | umls-concept:C0022671 | lld:lifeskim |
| pubmed-article:17705579 | lifeskim:mentions | umls-concept:C0072980 | lld:lifeskim |
| pubmed-article:17705579 | lifeskim:mentions | umls-concept:C0542341 | lld:lifeskim |
| pubmed-article:17705579 | lifeskim:mentions | umls-concept:C0205360 | lld:lifeskim |
| pubmed-article:17705579 | lifeskim:mentions | umls-concept:C0332293 | lld:lifeskim |
| pubmed-article:17705579 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:17705579 | pubmed:dateCreated | 2007-8-20 | lld:pubmed |
| pubmed-article:17705579 | pubmed:abstractText | Sirolimus is an agent with lymphocyte-specific features similar to those of calcineurin inhibitors but with a different mechanism of action and safety profile. To optimize the use of sirolimus-based immunosuppression, further investigation of appropriate pharmacokinetic (sirolimus exposure) and pharmacodynamic (sirolimus T-cell immunomodulator effect) monitoring is required to determine personalized target concentrations. | lld:pubmed |
| pubmed-article:17705579 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17705579 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17705579 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17705579 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17705579 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17705579 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17705579 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17705579 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17705579 | pubmed:issn | 1177-1062 | lld:pubmed |
| pubmed-article:17705579 | pubmed:author | pubmed-author:CampistolJose... | lld:pubmed |
| pubmed-article:17705579 | pubmed:author | pubmed-author:MillánOlgaO | lld:pubmed |
| pubmed-article:17705579 | pubmed:author | pubmed-author:BrunetMercèM | lld:pubmed |
| pubmed-article:17705579 | pubmed:author | pubmed-author:DiekmannFritz... | lld:pubmed |
| pubmed-article:17705579 | pubmed:author | pubmed-author:GuillenDavidD | lld:pubmed |
| pubmed-article:17705579 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17705579 | pubmed:volume | 11 | lld:pubmed |
| pubmed-article:17705579 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17705579 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17705579 | pubmed:pagination | 247-56 | lld:pubmed |
| pubmed-article:17705579 | pubmed:meshHeading | pubmed-meshheading:17705579... | lld:pubmed |
| pubmed-article:17705579 | pubmed:meshHeading | pubmed-meshheading:17705579... | lld:pubmed |
| pubmed-article:17705579 | pubmed:meshHeading | pubmed-meshheading:17705579... | lld:pubmed |
| pubmed-article:17705579 | pubmed:meshHeading | pubmed-meshheading:17705579... | lld:pubmed |
| pubmed-article:17705579 | pubmed:meshHeading | pubmed-meshheading:17705579... | lld:pubmed |
| pubmed-article:17705579 | pubmed:meshHeading | pubmed-meshheading:17705579... | lld:pubmed |
| pubmed-article:17705579 | pubmed:meshHeading | pubmed-meshheading:17705579... | lld:pubmed |
| pubmed-article:17705579 | pubmed:meshHeading | pubmed-meshheading:17705579... | lld:pubmed |
| pubmed-article:17705579 | pubmed:meshHeading | pubmed-meshheading:17705579... | lld:pubmed |
| pubmed-article:17705579 | pubmed:meshHeading | pubmed-meshheading:17705579... | lld:pubmed |
| pubmed-article:17705579 | pubmed:meshHeading | pubmed-meshheading:17705579... | lld:pubmed |
| pubmed-article:17705579 | pubmed:meshHeading | pubmed-meshheading:17705579... | lld:pubmed |
| pubmed-article:17705579 | pubmed:meshHeading | pubmed-meshheading:17705579... | lld:pubmed |
| pubmed-article:17705579 | pubmed:meshHeading | pubmed-meshheading:17705579... | lld:pubmed |
| pubmed-article:17705579 | pubmed:meshHeading | pubmed-meshheading:17705579... | lld:pubmed |
| pubmed-article:17705579 | pubmed:meshHeading | pubmed-meshheading:17705579... | lld:pubmed |
| pubmed-article:17705579 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17705579 | pubmed:articleTitle | T-cell function monitoring in stable renal transplant patients treated with sirolimus monotherapy. | lld:pubmed |
| pubmed-article:17705579 | pubmed:affiliation | Laboratorio de Farmacología, Centre de Diagnòstic Biomèdic, IDIBAPS, Hospital Clínic, Barcelona University, Barcelona, Spain. mbrunet@clinic.ub.es | lld:pubmed |
| pubmed-article:17705579 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17705579 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17705579 | lld:pubmed |
